Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Tolerx and the Cancer Research Institute partner for TRX-518

Dec. 3, 2010

AMT and Amgen amend licencing agreement for GDNF gene therapies

Dec. 3, 2010

Janssen and GE Healthcare to codevelop diagnostic for Alzheimer's disease

Dec. 2, 2010

Prometheus and AstraZeneca extend U.S. distribution agreement for Entocort EC

Dec. 2, 2010

Accentia forms strategic alliance with Baxter

Dec. 1, 2010

Anacor, UCSF and LFKRI team up to discover onchocerciasis therapies

Dec. 1, 2010

Immunovaccine and OncoTherapy Science join to develop cancer vaccine

Dec. 1, 2010

IntelGenx acquires rights to INT-0010 formulation of dronabinol

Nov. 30, 2010

Worldwide rights to pegsiticase acquired by 3SBio from EnzymeRx

Nov. 30, 2010

Medgenics extends Factor VIII Biopump collaboration

Nov. 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...